David Wither

Prof. David Wither obtained PhD in Immunology from the Institute for Animal in conjunction with the University of Bristol; following his PhD, he did a postdoc in the Peter Lipdsky’s lab at NIAMS, NIH, Bethseda. He then joined Peter Lane the University of Birmingham, where he cemented his interest in secondary lymphoid tissue development/structure, and how this controlled CD4 T cell responses. Carrying on from the previous research interest, Prof. Wither and his lab group currently have their research centred on the generation and development of T cell responses, particularly the development of memory CD4 T cells which are vital for immunological memory and thus vaccination. The lab is testing the role of RORgt-expressing group 3 Innate Lymphoid Cells versus other immune cell populations as checkpoints in adaptive immunity, both within secondary lymphoid tissue but also at mucosal barrier surfaces. Most recently, they developed novel approaches to track immune cell migration into and out of tumours, establishing innovative new models that can reveal fundamental information regarding anti-tumour immunity.

Lab Information

Institute of Immunology and Immunotherapy, University of Birmingham

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Immunotherapy 0 Immunology 0 T Cells 0 Innate Lymphoid Cells 0


  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)

This guy hasn’t posted anything yet.

Hot Posts for You

This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More

The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More

The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More

IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More

"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More

In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More

The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More

  1. Quraishi, MN, Acharjee, A, Beggs, AD, Horniblow, R, Tselepis, C, Gkoutos, G, Ghosh, S, Rossiter, A, Loman, N, van Schaik, W, Withers, D, Walters, JRF, Hirschfield, GM & Iqbal, TH 2020, 'A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways', Journal of Crohn's & Colitis. https://doi.org/10.1093/ecco-jcc/jjaa021

  2. Perez-Toledo, M, Beristain Covarrubias, N, Channell, W, Hitchcock, J, Jones, C, Coughlan, R, Bobat, S, Jones, N, Nakamura, K, Ross, E, Rossiter, A, Rooke, J, Garcia-Gimenez, A, Jossi, S, Persaud, R, Marcial-Juarez, E, Flores-Langarica, A, Henderson, I, Withers, D, Watson, S & Cunningham, A2020, 'Mice Deficient in T-bet Form Inducible NO Synthase–Positive Granulomas That Fail to Constrain Salmonella', Journal of Immunology, vol. 205, no. 2. https://doi.org/10.4049/jimmunol.2000089

  3. Gajdasik, DW, Gaspal, F, Halford, EE, Fiancette, R, Dutton, EE, Willis, C, Rückert, T, Romagnani, C, Gerard, A, Bevington, SL, MacDonald, AS, Botto, M, Withers, DR & Vyse, T 2020, 'Th1 responses in vivo require cell-specific provision of OX40L dictated by environmental cues', Nature Communications, vol. 11, no. 1, pp. 3421. https://doi.org/10.1038/s41467-020-17293-3

  4. Melo-Gonzalez, F, Kammoun, H, Evren, E, Dutton, EE, Papadopoulou, M, Bradford, BM, Tanes, C, Fardus-Reid, F, Swann, JR, Bittinger, K, Mabbott, NA, Vallance, BA, Willinger, T, Withers, DR & Hepworth, MR 2019, 'Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria', The Journal of Experimental Medicine, vol. 216, no. 4, pp. 728-742. https://doi.org/10.1084/jem.20180871

  5. Dutton, EE, Gajdasik, DW, Willis, C, Fiancette, R, Bishop, EL, Camelo, A, Sleeman, MA, Coccia, M, Didierlaurent, AM, Tomura, M, Pilataxi, F, Morehouse, CA, Carlesso, G & Withers, DR 2019, 'Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations', Science Immunology, vol. 4, no. 35, eaau8082. https://doi.org/10.1126/sciimmunol.aau8082

This guy hasn’t plasmids anything yet.

Hot plasmids

This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists
  • Beate Escher photo

    Beate Escher

    Helmholtz Centre for Environmental Research–UFZ

  • Dimitri Kullmann photo

    Dimitri Kullmann

    UCL Queen Squaree Institute of Neurology

  • Changhao Bi photo

    Changhao Bi

    Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud